Dr Reddy's Laboratories (FRA:RDDA) Cyclically Adjusted Book per Share: €2.86 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RDDA Dr Reddy's Laboratories Ltd FRA:RDDA
91 GF Score
Price €10.60
GF Value €11.95
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dr Reddy's Laboratories Cyclically Adjusted Book per Share?

Dr Reddy's Laboratories FRA:RDDA 91 Cyclically Adjusted Book per Share is €2.86 as of Jun. 2026. GuruFocus rates FRA:RDDA with a GF Score™ of 91/100 and a GF Value™ of €11.95 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Dr Reddy's Laboratories's adjusted book value per share for the three months ended in Jun. 2026 was €4.208. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.86 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Dr Reddy's Laboratories's average Cyclically Adjusted Book Growth Rate was 12.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Dr Reddy's Laboratories was 14.20% per year. The lowest was 8.90% per year. And the median was 12.00% per year.

As of today (2026-08-17), Dr Reddy's Laboratories's current stock price is €10.60. Dr Reddy's Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €2.86. Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio of today is 3.71.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr Reddy's Laboratories was 6.94. The lowest was 3.25. And the median was 4.63.


Dr Reddy's Laboratories  (FRA:RDDA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.60/2.86
=3.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr Reddy's Laboratories was 6.94. The lowest was 3.25. And the median was 4.63.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Dr Reddy's Laboratories Cyclically Adjusted Book per Share Related Terms


Dr Reddy's Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Dr Reddy's Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories Cyclically Adjusted Book per Share Chart

Dr Reddy's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.20 2.39 2.63 2.79 2.69

Dr Reddy's Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.65 2.65 2.64 2.69 2.86

FRA:RDDA vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio falls into.


FRA:RDDA
91GF Score
Dr Reddy's Laboratories Ltd FRA:RDDA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Reddy's Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr Reddy's Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.208/167.3573*167.3573
=4.208

Current CPI (Jun. 2026) = 167.3573.

Dr Reddy's Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.858 105.961 2.935
201612 2.042 105.196 3.249
201703 2.127 105.196 3.384
201706 2.056 107.109 3.212
201709 1.912 109.021 2.935
201712 1.961 109.404 3.000
201803 1.901 109.786 2.898
201806 1.985 111.317 2.984
201809 1.878 115.142 2.730
201812 2.031 115.142 2.952
201903 2.153 118.202 3.048
201906 2.251 120.880 3.116
201909 2.363 123.175 3.211
201912 2.269 126.235 3.008
202003 2.270 124.705 3.046
202006 2.288 127.000 3.015
202009 2.302 130.118 2.961
202012 2.280 130.889 2.915
202103 2.409 131.771 3.060
202106 2.423 134.084 3.024
202109 2.552 135.847 3.144
202112 2.681 138.161 3.248
202203 2.736 138.822 3.298
202206 2.925 142.347 3.439
202209 3.127 144.661 3.618
202212 3.036 145.763 3.486
202303 3.157 146.865 3.598
202306 3.313 150.280 3.689
202309 3.429 151.492 3.788
202312 3.544 152.924 3.878
202403 3.734 153.035 4.083
202406 3.938 155.789 4.230
202409 3.941 157.882 4.178
202412 4.286 158.323 4.531
202503 4.284 157.552 4.551
202506 4.246 159.755 4.448
202509 4.154 162.289 4.284
202512 4.242 163.281 4.348
202603 4.220 164.272 4.299
202606 4.208 167.357 4.208

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €2.86 mean?
Dr Reddy's Laboratories (FRA:RDDA) has a Cyclically Adjusted Book per Share of €2.86 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr Reddy's Laboratories and its competitors.
Is Dr Reddy's Laboratories' Cyclically Adjusted Book per Share too high?
Dr Reddy's Laboratories' current Cyclically Adjusted Book per Share is €2.86. Overall, Dr Reddy's Laboratories has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Reddy's Laboratories' Cyclically Adjusted Book per Share compare to ZTS?
Dr Reddy's Laboratories' Cyclically Adjusted Book per Share of €2.86 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr Reddy's Laboratories and its competitors. Dr Reddy's Laboratories's current Cyclically Adjusted Book per Share is €2.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Reddy's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Dr Reddy's Laboratories (FRA:RDDA) is currently considered Modestly Undervalued. The stock's GF Value™ is €11.95, compared to a current price of €10.60 — trading 11.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is €2.86. Dr Reddy's Laboratories' overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Dr Reddy's Laboratories (FRA:RDDA), the current Cyclically Adjusted Book per Share is €2.86 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Reddy's Laboratories (FRA:RDDA) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Reddy's Laboratories stock appears to be undervalued. The current stock price of €10.60 is trading 11.3% below its estimated GF Value™ of €11.95. GuruFocus considers Dr Reddy's Laboratories to be Modestly Undervalued.

Key valuation signals for FRA:RDDA:

  • Cyclically Adjusted Book per Share: €2.86
  • GF Value™: €11.95 vs. price of €10.60 (11.3% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the FRA:RDDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Reddy's Laboratories Business Description

Address 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
91GF Score

Get the complete analysis for FRA:RDDA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.60
Price
€11.95
GF Value